Advertising feature from Novartis Gene Therapies

Spinal Muscular Atrophy (SMA) is a rare, genetic condition that affects around 70 babies each year, with approximately one baby being born with SMA every five days in the UK. SMA is characterised by the loss of motor neurons in the spinal cord and, if left untreated, babies affected will experience progressive muscle weakness and

Over the past 20 months, the Covid-19 pandemic has shone a light on underlying healthcare issues and inequalities in the UK. To add to this, our health and care needs are changing. Lifestyle choices are increasing our risk of preventable disease and affecting wellbeing, as we continue to live longer with multiple long-term conditions such